Psychogenic erectile dysfunction

International Journal of Psychiatry in Medicine

Volumn 33, Issue 3, 2003, Pages 273-293

  Bodie, Joshua A ^a   Beeman, William W ^a   Monga, Manoj ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Depression; Erectile dysfunction; Impotence; Psychiatry; Psychogenic

Indexed keywords

ACEBUTOLOL; AMFEBUTAMONE; AMITRIPTYLINE; AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CHLORTALIDONE; CITALOPRAM; CLOMIPRAMINE; ENALAPRIL; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; INDAPAMIDE; LISINOPRIL; METOPROLOL; MIRTAZAPINE; NADOLOL; NEFAZODONE; NEUROLEPTIC AGENT; PAROXETINE; PHENELZINE; PIMOZIDE; PINDOLOL; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; UNINDEXED DRUG; VENLAFAXINE;

ADULT; AROUSAL; ARTICLE; BEHAVIOR THERAPY; CASE REPORT; COGNITIVE THERAPY; CONTROLLED DRUG RELEASE; DEPRESSION; DIAGNOSTIC APPROACH ROUTE; DRUG FORMULATION; ERECTILE DYSFUNCTION; HEALTH PRACTITIONER; HUMAN; LIFE; MALE; MEDICAL EDUCATION; MEDICAL LITERATURE; MEDLINE; ORGANIC IMPOTENCE; PSYCHIATRY; PSYCHOGENIC IMPOTENCE; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; PSYCINFO; REVIEW; SEXUALITY; TREATMENT PLANNING; UROLOGY;

COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PIPERAZINES; PSYCHOMETRICS; VASODILATOR AGENTS;

EID: 1542470345     PISSN: 00912174     EISSN: None     Source Type: Journal    
DOI: 10.2190/NHV6-3DYB-X51G-4BVM     Document Type: Review

References (69)

1. NIH Consensus Development Panel On Impotence. Impotence. Journal of the American Medical Association 1993;270:83-90.
2. Panser LA, Rhodes T, Girman CJ, Guess HA, Chute CG, Oesterling JE, Lieber MM, Jacobsen SJ. Sexual function of men ages 40-79 years: The Olmsted County study of urinary symptoms and health status among men. Journal of the American Geriatric Society 1995;43:1107-1111.
3. Seidman SN. Exploring the relationship between depression and erectile dysfunction in aging men. Journal of Clinical Psychiatry 2002;63(sup 5):5-12.
4. Prins J, Blanker MH, Bohnen AM, Thomas S, Bosch JLHR. Prevalence of erectile dysfunction: A systematic review of population-based studies. International Journal of Impotence Research 2002;14:422-432.
5. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. Journal of the American Medical Association 1999;281:537-544.
6. Kubin M, Wagner G, Fugl-Meyer AR. Epidemiology of erectile dysfunction. International Journal of Impotence Research 2003;15(1):63-71.
7. Dunn KM, Croft PR, Hackett GI. Association of sexual problems with social, psychological, and physical problems in men and women: A cross sectional population survey. Journal of Epidemiology and Community Health 1999;53:144-148.
8. Hartmann U. Psychological evaluation and psychometry. In: Jonas U, Thon WF, Stief CG, editors. Erectile dysfunction. Berlin: Springer-Verlag, 1991:93-103.
9. Beutel M. Psychosomatic aspects in the diagnosis and treatment of erectile dysfunction. Andrologia 1999;31(suppl 1):37-44.
10. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinaly JB. Impotence and its medical and psychosocial correlates. Results of Massachusetts Male Aging Study. Journal of Urology 1994;151:54-61.
11. Monga M, Bettencourt R, Barrett-Connor E. Community-based study of erectile dysfunction and sildenafil use: The Rancho Bernardo study. Urology 2002;59(5):753-757.
12. Araujo AB, Durante R, Feldman HA, McKinlay JB. The relationship between depressive symptoms and male erectile dysfunction: Cross-sectional results from the Massachusetts Male Aging Study. Psychosomatic Medicine 1998;60:458-465.
13. Cosgrove DJ, Gordon Z, Bernie JE, Hami S, Montoya D, Stein MB, Monga M. Sexual dysfunction in combat veterans with post-traumatic stress disorder. Urology 2002;60(5):881-884.
14. Shabsigh R, Klein LT, Seidman S, Kaplan SA, Lehrhoff BJ, Ritter JS. Increased incidence of depressive symptoms in men with erectile dysfunction. Urology 1998;52:848-852.
15. Rosen R. Psychogenic erectile dysfunction, classification and management. The Urologic Clinics of North America 2001;28(2):269-278.
16. Shabsigh R, Zakaria L, Anastasiadis AG, Seidman SN. Sexual dysfunction and depression: Etiology, prevalence, and treatment. Current Urology Reports 2001;2:463-467.
17. Lee IC, Surridge D, Morales A, Heaton JP. The prevalence and influence of significant psychiatric abnormalities in men undergoing comprehensive management of organic erectile dysfunction. International Journal of Impotence Research 2000;12:47-51.
18. Seidman S, Roose S, Menza M, Shabsigh R, Rosen RC. Treatment of erectile dysfunction in men with depressive symptoms: Results of a placebo-controlled trial with sildenafil citrate. The American Journal of Psychiatry 2001;158:1623-1630.
19. Ekselius L, Von Knorring L. Effect on sexual function of long-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care. Journal of Clinical Psychopharmacology 2001;21:154-160.
20. Jackson DN. Personality researchform manual. Post Huron, MI: Sigma Assessment Systems, Inc., 1989.
21. Araujo AB, Johannes CB, Feldman HA, Derby CA, McKinlay JB. Relation between psychosocial risk factors and incident erectile dysfunction: Prospective results from the Massachusetts Male Aging Study. American Journal of Epidemiology 2000;152:533-541.
22. Nurnberg HG, Seidman SN, Gelenberg AJ, Fava M, Rosen R, Shabsigh R. Depression, antidepressant therapies, and erectile dysfunction: Clinical trials of sildenafil citrate (Viagra) in treated and untreated patients with depression. Urology 2002;60(suppl 2B):58-66.
23. Nurnberg HG, Hensley PL, Gelenberg AJ, Fava M, Lauriello J, Paine S. Treatment of antidepressant-associated sexual dysfunction with sildenafil - A randomized controlled trial. Journal of the American Medical Association 2003;289:56-64.
24. Scott J, Pope M. Nonadherence with mood stabilizers: Prevalence and predictors. Journal of Clinical Psychiatry 2002;63(5):384-390.
25. Muller MJ, Benkert O. Lower self-reported depression in patients with erectile dysfunction after treatment with sildenafil. Journal of Affective Disorders 2001;66:255-261.
26. Muller MJ, Ruof J, Graf-Morgenstern M, Porst H, Benkert O. Quality of partnership in patients with erectile dysfunction after sildenafil treatment. Pharmacopsychiatry 2001;34:91-95.
27. MacDonagh R, Ewings P, Porter T. The effect of erectile dysfunction on quality of life: Psychometric testing of a new quality of life measure for patients with erectile dysfunction. Journal of Urology 2002;167:212-217.
28. Wagner G, Fugl-Meyer KS, Fugl-Meyer AR. Impact of erectile dysfunction on quality of life: Patient and partner perspectives. International Journal of Impotence Research 2000;12(suppl 4):S144-S146.
29. Rosen RC. Quality of life assessment in sexual dysfunction trials. International Journal of Impotence Research 1998;10(Suppl 2):S21-S23.
30. Williams G, Abbou CC, Amar ET, Desvaux P, Flam TA, Lycklama a Nijeholt GA, Lynch SF, Morgan RJ, Muller SC, Porst H, Pryor JP, Ryan P, Witzsch UK, Hall MM, Place VA, Spivack AP, Todd LK, Gesundheit N. The effect of transurethral alprostadil on the quality of life of men with erectile dysfunction, and their partners. MUSE Study Group. British Journal of Urology 1998;82(6):847-854.
31. Fugl-Meyer KS. Erectile problems - The perspective of the female. Scandinavian Journal of Urology and Nephrology 1998;32(suppl 197):12.
32. Masters WH, Johnson SE. Human sexual inadequacy. Boston, MA: Little Brown, 1970.
33. McDowell A, Snellgrove C, Bond M. Beyond Viagra: Psychological issues in the assessment and treatment of erectile dysfunction. Australian Family Physician 2001;30:867-873.
34. Rosen RC, Leiblum SR. Erectile disorders: Historical trends and clinical perspectives. In: Rosen RC, Leiblum SR, editors. Erectile disorders: Assessment and treatment. New York: Guilford Press, 1992:3-26.
35. McCabe MP. Intimacy and quality of life among sexually dysfunctional men and women. Journal of Sex and Marital Therapy 1997;23:276-290.
36. Hawton K, Catalan J, Fagg J. Sex therapy for erectile dysfunction: Characteristics of couples, treatment outcome, and prognostic factors. Archives of Sexual Behavior 1992;21(2):161-175.
37. Bancroft J. Psychogenic erectile dysfunction. International Journal of Impotence Research 2000;12(suppl 3):S46-S48.
38. Barlow DH. Causes of sexual dysfunction: The role of anxiety and cognitive interference. Journal of Consulting and Clinical Psychology 1986;54:140-148.
39. Morgentaler A. Male impotence. Lancet 1999;354:1713-1718.
40. Fishbain D. Impact of sildenafil citrate (Viagra) on the DSM-IV diagnosis of male erectile disorder due to psychological factors. Urology 1999;54:579.
41. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition. Text revision Washington, DC: American Psychiatric Association, 2000.
42. Latini DM, Penson DF, Colwell, HH, Lubeck DP, Mehta SS, Henning JM, Lue TF. Psychological impact of erectile dysfunction: Validation of a new health relates quality of life measure for patients with erectile dysfunction. The Journal of Urology 2002;168:2086-2091.
43. Goldstein I. The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction. American Journal of Cardiology 2000;86(2A):41F-45F.
44. Shires A, Miller D. A preliminary study comparing psychological factors associated with erectile dysfunction in heterosexual and homosexual men. Sexual & Marital Therapy 1998;13(1):37-49.
45. Laudat A, Blum L, Guechot J, Picard O, Cabane J, Imbert JC, Giboudeau J. Changes in systemic gonadal and adrenal steroids in asymptomatic human immunodeficiency virus-infected men: Relationship with the CD4 cell counts. European Journal of Endocrinology 1995;133(4):418-424.
46. Keene LC, Davies PH. Drug-related erectile dysfunction. Adverse Drug Reactions & Toxicological Reviews 1999;18(1):5-24.
47. Fecik S. Drug-induced sexual dysfunction. Medical Update for Psychiatrists 1998;3:176-181.
48. Mann K, Abbott E, Gray J. Sexual dysfunction with beta-blocker therapy: More common than we think? Sex Disability 1982;5:67-77.
49. TOMHS Study Group. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension 1997;29:8-14.
50. Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson C, Bass KI, Donahue RMJ, Jamerson BD, Metz A. Prevalence of sexual dysfunction among newer antidepressants. Journal of Clinical Psychiatry 2002;63(4):357-366.
51. Hsu JH, Shen WW. Male sexual side-effects associated with antidepressants: A descriptive clinical study of 32 patients. International Journal of Psychiatry in Medicine 1995;25:191-201.
52. Schiavi RC, Segraves RT. The biology of sexual function. Psychiatric Clinics of North America 1995;18:7-23.
53. Rosen RC. Erectile dysfunction: The medicalization of male sexuality. Clinical Psychology Review 1996;16(6):497-519.
54. Sarwer DB, Durlak JA. A field trial of the effectiveness of behavioral treatment for sexual dysfunctions. Journal of Sex & Marital Therapy 1997;23(2):87-97.
55. Wylie KR. Treatment outcome of brief couple therapy in psychogenic male erectile disorder. Archives of Sexual Behavior 1997;26(5):527-545.
56. Nusbaum MR, Hamilton C, Lenahan P. Chronic illness and sexual functioning. American Family Physician 2003;67(2):347-354.
57. Dauw DC. Evaluating the effectiveness of the SECS' surrogate-assisted sex therapy model. Journal of Sex Research 1988;24:269-275.
58. Apfelbaum, B. The myth of the surrogate. Journal of Sex Research 1977;13(4):238-249.
59. Leiblum SR, Segraves RT: Sex therapy with aging adults. In: Leiblum SR, Rosen RC, editors. Principles and practice of sex therapy: Update for the 1990s. New York: Guilford Press, 1989:352-381.
60. Monga M, Jain A, Phelps J. The co-ordinated approach to erectile dysfunction: Psychoeducational and pharmacological interventions (Abstract). Journal of Urology 2002;167:282.
61. Leiblum SR. After sildenafil: Bridging the gap between pharmacologic treatment and satisfying sexual relationships. Journal of Clinical Psychiatry 2002;63 (suppl 5):17-22.
62. Salonia A, Maga T, Colombo R, Scattoni V, Briganti A, Cestari A, Guazzoni G, Rigatti P, Montorsi F. A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. Journal of Urology 2002;168(6):2486-2489.
63. McMahon CG, Samali R. Pharmacological treatment of premature ejaculation. Current Opinion in Urology 1999;9(6):553-561.
64. Strassberg DS, de Gouveia Brazao CA, Rowland DL, Tan P, Slob AK. Clomipramine in the treatment of rapid (premature) ejaculation. Journal of Sex & Marital Therapy 1999;25(2):89-101.
65. Eardley I, Cartledge J. Tadalafil (Cialis) for men with erectile dysfunction. International Journal of Clinical Practice 2002;56(4):300-304.
66. Klotz T, Sachse R, Heidrich A, Jockenhovel F, Rohde G, Wensing G, Horstmann R, Engelmann R. Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: A RigiScan and pharmacokinetic study. World Journal of Urology 2001;19(1):32-39.
67. Miller TA. Diagnostic evaluation of erectile dysfunction. American Family Physician 2000;61(1):95-104.
68. Tiefer L. The medicalization of sexuality: Conceptual, normative and professional issues. Annual Review of Sex Research 1996;7:252-282.
69. Bass BA. Behavior therapy and the medicalization of male sexuality. Behavior Therapist 2002;25(9):167-168.